Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vaccine
Biotech
Pfizer ‘comfortable’ joining fights with hantavirus, Ebola: exec
As Pfizer endeavors to stymie a suite of bacterial infections, the COVID-19 vaccine maker continues to keep an eye on emerging public health threats.
Darren Incorvaia
May 20, 2026 5:05am
HHS stands behind FDA decision to spurn Moderna flu filing
Feb 11, 2026 3:13pm
US vaccine landscape ‘100%’ impacting business: Bancel
Jan 23, 2026 1:26pm
Moderna winds down 3 mRNA programs
Nov 20, 2025 4:10pm
Experiments reveal targets for new tuberculosis vaccines
Nov 7, 2025 5:15am
Moderna scraps congenital virus program after vax fails ph. 3
Oct 22, 2025 5:15pm
